VA launches nationwide trial of GLP-1 drug for alcohol use disorder

The U.S. Department of Veterans Affairs is launching a clinical trial to evaluate whether semaglutide, a GLP-1 receptor agonist used to treat diabetes, can treat alcohol use disorder among veterans.

Episode metadata supplied by the publisher feed · Published Aug 10, 2026

Embed this episode

Attribution link and audio player

Ready to play

VA launches nationwide trial of GLP-1 drug for alcohol use disorder

0:00 1:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of SuperTalk Mississippi News?

This episode is 1 minute long.

When was this SuperTalk Mississippi News episode published?

This episode was published on August 10, 2026.

Can I download this SuperTalk Mississippi News episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!